Appointments
See all of our Talent Tuesday and Health IT Appointments and Hires posts.
Ambience Healthcare Appoints Michael Han, MD, MBA as Chief Medical Officer
Ambience Healthcare, an AI platform for clinical documentation and revenue integrity, announced the appointment of Michael Han, MD, MBA as Chief Medical Officer (CMO). In this role, Dr. Han will lead Ambience’s clinical strategy as the company continues to expand beyond ambient documentation into a broader system of intelligence designed to help health systems apply AI to rethink clinical workflow, revenue integrity, and operational performance at scale.
Cityblock Health Appoints New Chief Health Officer to Advance Technology-Enabled Clinical Care Model for Government Programs
Cityblock Health, a value-based healthcare provider for Medicaid and dually eligible beneficiaries, announced the appointment of their new Chief Health Officer, Alexander Billioux, M.D., who will lead the organization’s clinical strategy and care operations. Dr. Billioux brings deep expertise as a physician, public health leader, and healthcare executive as Cityblock advances its technology-enabled care model for vulnerable communities.
Pivot Point Consulting Appoints Veteran Healthcare Finance Executive Thomas Kaylor as Chief Financial Officer
Pivot Point Consulting, a Best in KLAS healthcare IT consulting leader, announced the appointment of Thomas Kaylor as chief financial officer. As Pivot Point Consulting enters its next phase of growth following its combination with Innovative Consulting Group, Kaylor will lead the firm’s financial strategy and support its continued expansion across providers, payers, life sciences, and technology organizations nationwide.
Sandhills Medical Appoints Amanda Duke as Chief Executive Officer
Sandhills Medical, a quality-award-winning Federally Qualified Health Center (FQHC) in South Carolina, announced the appointment of Amanda Duke as Chief Executive Officer. A former registered nurse with more than 30 years in healthcare executive leadership, Duke is singularly focused on initiatives that will advance and expand community access to quality, comprehensive and cost-effective health care.
MyOme Strengthens Board with Appointment of Two Healthcare Leaders
MyOme, a genomics innovation and risk modeling company, announced the appointment of Sam Roosz and Dr. Ravi Thadhani to its Board of Directors. The two executives bring deep expertise spanning healthcare technology, data portability, clinical trials, population health, and regulatory strategy, strengthening MyOme’s position as it expands its AI-powered whole-genome healthcare platform.
ChronicCareIQ Appoints Venkata Reddy Gogulamudi as CTO
ChronicCareIQ, the most highly rated care management software by doctors and patients on Google Play and the Apple App store, announced the appointment of Venkata Reddy Gogulamudi as Chief Technology Officer.
Enlace Health Appoints Former Blue Cross and Blue Shield of Minnesota CEO Craig Samitt, MD, to Board of Directors as it Scales Its Specialty Care Operating System
Enlace Health announced that Dr. Craig Samitt, a nationally recognized physician leader and healthcare executive, has joined its Board of Directors. Dr. Samitt brings deep experience leading healthcare organizations to improve affordability, coordination, and performance – particularly in complex specialty care models.
Aledade Appoints Oraida Roman as Chief Commercial Officer to Lead Health Plan Partnerships Strategy
Aledade, a physician‑led, national leader in value‑based care, announced the appointment of Oraida Roman as its new chief commercial officer. In this role, Roman will lead the company’s strategy for health plan partnerships, focusing on creating strong alignment among health plans and Aledade’s primary care partners to deliver better health care and improve affordability.
Valo Health Appoints Chris Anagnostopoulos, PhD, as Chief Causal AI Officer
Valo Health, Inc., a pioneer in the use of human data and AI to accelerate drug discovery and development, announced the appointment of Chris Anagnostopoulos, PhD, C.Stat, to the newly created position of Chief Causal AI Officer. In this role, Dr. Anagnostopoulos will lead the advancement of Valo’s human causal biology platform, translating large-scale, real‑world human data into causal insights that inform drug discovery.
IO Health Appoints Chet Robson, DO, MHCDS, FAAFP as Chief Medical Officer
IO Health, the AI intelligence layer for home health and hospice agencies on Homecare Homebase (HCHB), announced the appointment of Chet Robson, DO, MHCDS, FAAFP as Chief Medical Officer. Dr. Robson previously served as Chief Clinical Officer at Walgreens, directing clinical integrity across pharmacy and retail health operations and leading the WBA global pandemic response with HHS and the CDC.
Hires, Promotions, & Accolades
symplr Names Venkat Kavarthapu Chief Executive Officer
symplr®, a company in enterprise healthcare operations software backed by Clearlake Capital Group, L.P. (together with its affiliates, Clearlake) and Charlesbank Capital Partners (Charlesbank), announced the appointment of Venkat Kavarthapu as Chief Executive Officer, effective immediately. He succeeds Chris Colpitts, who has served as interim CEO since November 2025. Mr. Colpitts will continue in his role as Executive Chairman of the Board and will support a seamless leadership transition.
Navista Welcomes Lalan Wilfong, MD, as Chief Medical Officer
Navista, Cardinal Health’s oncology practice alliance, announced the appointment of Lalan Wilfong, MD, as Chief Medical Officer. In this role, Dr. Wilfong will support clinical strategy for Navista, collaborating as a trusted clinical voice across the alliance. As Chief Medical Officer, Dr. Wilfong will aid development and adoption of evidence‑based pathways, advance value‑based care initiatives and assist practices in bringing advanced therapies to the community setting amid a rapidly evolving therapeutic landscape.
Humana Elects Robert S. Field to Board of Directors
Humana Inc. announced that Robert S. Field has been elected as a member of the Company’s Board of Directors, effective immediately following the Company’s 2026 Annual Meeting of Stockholders.